Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Pfizer
- Study ID
- NCT05207865
- Phase
- PHASE4
- Status
- Completed
Conditions
- Episodic Migraine
- Migraine
- Phonophobia
- Photophobia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Rimegepant — DRUGrimegepant ODT 75mg daily
Study Details
The purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic migraine.
Key Dates
- Start date
- Mar 15, 2022
- Status verified
- Jul 2025
- Primary completion
- Jul 2, 2024
- Completion
- Jul 2, 2024
Study Design
- Enrollment
- 441 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Rimegepantrimegepant 75 mg ODT daily
Primary Outcome Measure
Number of Participants With On-Treatment Adverse Events (AEs) (Frequency >=5%) According to Intensity [ Time Frame: From start of study treatment (Day 1) up to 7 days after the last dose of study treatment (Up to 25 weeks) ]
Locations (19)
Related coverage on Hipa.ai
- Rimegepant Daily Dosing for Episodic Migraine Prevention Shows Favorable…Rimegepant · Sep 3, 2025 · ClinicalTrials.gov
Find similar trials in Phoenix, AZ
By condition
By specialty
Related Studies
- Pain Biomarker StudyPHASE1 · Enrolling By Invitation · The University of Texas Health Science Center, Houston · Houston, Texas
- Mind Body Balance for Pediatric MigraineRecruiting · Children's Hospital Medical Center, Cincinnati · Aurora, Colorado
- Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial PainPHASE2 · Recruiting · Stanford University · Stanford, California
- Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)PHASE3 · Recruiting · AbbVie · Huntsville, Alabama